supp.fit

Docosahexaenoic Acid and Eicosapentaenoic Acid: study protocols

36 study groups took Docosahexaenoic Acid together with Eicosapentaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Docosahexaenoic Acid: what the research found →

Dose per serving from research: Docosahexaenoic Acid

36 study groups in 31 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 39% of 36 study groups.

Daily doseStudy groups
100 mg to 250 mg
7
250 mg to 500 mg
5
500 mg to 1 g
9
1 g to 2.5 g
14
over 2.5 g
1

Dose per serving from research: Eicosapentaenoic Acid

35 study groups in 30 studies say how much Eicosapentaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 29% of 35 study groups.

Daily doseStudy groups
50 mg or less
1
50 mg to 100 mg
3
100 mg to 250 mg
9
250 mg to 500 mg
7
500 mg to 1 g
1
1 g to 2.5 g
10
2.5 g to 5 g
4

Commonly used together

26 of 36 study groups took Docosahexaenoic Acid and Eicosapentaenoic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Fish Oil
19
Omega-3 Fatty Acids
5

36 study groups

Study
Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users
2016 · O3FA group · Young and middle-aged visual display terminal users with dry eye symptoms
240 mg360 mg45 days256
Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
2009 · fish-oil intervention group · Adults with metabolic syndrome; mean age 52.9 years; sex not specified
120 mg180 mg26 weeks60
Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial
2012 · n-3 LCPUFA group · Pregnant women from Adelaide whose unborn baby had a mother, father, or sibling with a history of medically diagnosed allergic disease
800 mg100 mg—368
Effect of a Novel Omega-3 and Omega-6 Fatty Acid Supplement on Dry Eye Disease: A 3-month Randomized Controlled Trial
2022 · treatment supplement · Participants with moderate to severe dry eye disease
300 mg1.2 g90 days24
Prenatal Fish Oil Supplementation and Allergy: 6-Year Follow-up of a Randomized Controlled Trial
2016 · n-3 LCPUFA-rich fish oil capsules · Pregnant women with a family history of allergic disease
800 mg100 mg—367
The effect of perinatal fish oil supplementation on neurodevelopment and growth of infants: a randomized controlled trial
2018 · fish oil supplementation group · Pregnant women aged 18–35 years
120 mg180 mg—75
Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions
2006 · omega-3 fatty acids · White men with a history of myocardial infarction and ejection fractions below 40%
585 mg225 mg120 days—
Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
2007 · omega-3 fatty acids · Children aged 5 to 17 years with autistic disorders accompanied by severe tantrums, aggression, or self-injurious behavior
700 mg840 mg6 weeks—
Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics
2013 · fish-oil supplementation · Adult men with alcohol dependence undergoing residential rehabilitation
252 mg60 mg3 weeks—
Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial
2017 · omega-3 PUFAs · Japanese accident survivors who began supplementation within 10 days of accidental injury
1.47 g147 mg12 weeks—
Effects of fish oil and curcumin supplementation on cerebrovascular function in older adults: A randomized controlled trial
2020 · fish oil · Sedentary overweight/obese adults aged 50–80 years
2 g400 mg16 weeks—
Effects of fish oil and curcumin supplementation on cerebrovascular function in older adults: A randomized controlled trial
2020 · combination of fish oil and curcumin · Sedentary overweight/obese adults aged 50–80 years
2 g400 mg16 weeks—
Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: Secondary analysis of data from a randomized controlled trial
2024 · n-3 PUFAs supplementation · Outpatients with first-diagnosed, drug-naïve depression receiving venlafaxine; age and sex not reported
960 mg1.44 g12 weeks—
Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans
2011 · Active group · People with subjective symptoms of asthenopia; age and sex not reported
783 mg162 mg4 weeks11
Effects of a Long Chain n-3 Polyunsaturated Fatty Acid-rich Multi-ingredient Nutrition Supplement on Body Composition and Physical Function in Older Adults with Low Skeletal Muscle Mass
2022 · supplement (SUPP) · Community-dwelling older adults with low skeletal muscle mass; mean age 74.9 years; 18 men and 19 women in the study overall
1.5 g1.5 g26 weeks—
Fish oil amplifies the effect of propranolol in mild essential hypertension
1990 · Third subgroup: propranolol plus fish oil · Men with mild essential hypertension
1.1 g1.8 g12 weeks16
The effects of supplemental fish oil on blood pressure and morning cortisol in normotensive adults: a pilot study
2012 · Fish Oil (FO) · Adults, mean age 35±13 years, normotensive
800 mg1.6 g6 weeks—
Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial
2014 · eicosapentaenoic acid-docosahexaenoic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men.
159 mg239 mg1200 days—
Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach
2020 · n-3 PUFA supplementation · Adults; age, sex, and health condition not specified
1.1 g—6 weeks210
Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study
2002 · group 2 (Maxigard group) · Adults with type 2 diabetes and BMI <27 kg/m²; age and sex not specified
240 mg360 mg6 weeks25
Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients
2014 · omega-3 group · Adults undergoing maintenance hemodialysis
720 mg1.08 g120 days25
[Metabolic syndrome reversion by polyunsaturated fatty acids ingestion]
2013 · n-3 group · Adults with metabolic syndrome
720 mg1.08 g6 weeks15
Supplementation with dietary ω-3 mitigates immobilization-induced reductions in skeletal muscle mitochondrial respiration in young women
2019 · ω-3 supplementation · Healthy young women, age 22 ± 3 years
2 g3 g6 weeks11
The influence of low intake of n-3 fatty acids on platelets in elderly people
1999 · n-3 PUFA group · healthy elderly people; age range and sex not stated
150 mg30 mg6 weeks10
Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer
1992 · fish oil group · Patients with sporadic adenomatous colorectal polyps; age and sex not reported
3.6 g4.1 g12 weeks10
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects
1994 · fish oil · Subjects without cystic fibrosis; mean age 13.4 years
2.2 g3.2 g6 weeks8
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects
1994 · fish oil · Patients with cystic fibrosis and pancreatic insufficiency; mean age 12.2 years
2.2 g3.2 g6 weeks7
Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women
2008 · fish oil (FO) · pregnant women; age and health condition not specified
500 mg150 mg——
[Effect on the lipid profile of diet supplemented with fish oil concentrate]
1990 · n-3 treated group · male and female patients with cholesterol values higher than 7.0 mmol/l
1.5 g2.1 g12 weeks—
Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial
2014 · eicosapentaenoic acid-docosahexaenoic acid plus α-linolenic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men.
159 mg239 mg1200 days—
Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles
2017 · SFA-rich diet · Healthy subjects; age and sex not reported
2 g400 mg6 weeks—
Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles
2017 · n-6PUFA-rich diet · Healthy subjects; age and sex not reported
2 g400 mg6 weeks—
Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis
1995 · fish oil treatment group · Patients with mild rheumatoid arthritis; age and sex not reported
1.1 g1.7 g26 weeks—
The immunomodulatory effects of fish-oil supplementation in elite paddlers: A pilot randomized double blind placebo-controlled trial
2015 · fish-oil capsules · male elite paddlers undertaking an increasing exercise program
1.2 g2.4 g4 weeks11
Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye
2011 · omega-3 group · Patients with dry eye; age and sex not reported
300 mg450 mg90 days—
Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women
2008 · fish oil (FO) and methyl-tetra-hydrofolic acid · pregnant women; age and health condition not specified
500 mg150 mg——